340B Drug Pricing Program New Error-Ridden 340B Study Misses the Mark Feb 7, 2024 By Bharath Krishnamurthy, Director, Pharmaceutical Policy, American Hospital Association, Aimee Kuhlman, VP Advocacy Grassroots, Government Relations A new study published in the New England Journal of Medicine demonstrates a stunning lack of understanding of the 340B drug pricing program and the overall landscape of drug pricing.
340B Drug Pricing Program Restoring the 340B OPPS Payment Policy: Good for Patients, Good for Providers Sep 21, 2022 By Bharath Krishnamurthy, Director, Pharmaceutical Policy, American Hospital Association, Aimee Kuhlman, VP Advocacy Grassroots, Government Relations In July, the Centers for Medicare & Medicaid Services published its annual outpatient prospective payment system regulation.
